INVESTIGATION REMINDER ALERT: The Schall Law Firm Announces it is Investigating Claims Against Ampio Pharmaceuticals, Inc. & ...
August 10 2018 - 8:38AM
Business Wire
The Schall Law Firm, a national shareholder rights litigation
firm, announces that it is investigating claims on behalf of
investors of Ampio Pharmaceuticals, Inc. (“Ampio” or “the Company”)
(NYSE: AMPE) for violations of §§10(b) and 20(a) of the Securities
Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the
U.S. Securities and Exchange Commission.
The investigation focuses on whether the Company issued false
and/or misleading statements and/or failed to disclose information
pertinent to investors. Ampio filed a Form 8-K with the SEC after
regular trading hours ended on August 7, 2018. The purpose of the
Form 8-K was to provide an update on the FDA’s review of Ampion,
and specifically the AP-003-A and AP-003-C trials. Ampio informed
the market that it met with the FDA in July, 2018, and received a
response letter after that meeting which stated, “as a single
trial[,] the AP-003-A study alone does not appear to provide
sufficient evidence of effectiveness to support [the Biologics
License Application].” The FDA also stated, “the FDA does not
consider the AP-003-C trial to be an adequate and well-controlled
clinical trial.” Based on this news, shares of Ampio fell almost
79% on August 8, 2018.
If you are a shareholder who suffered a loss, click here to
participate.
We also encourage you to contact Brian Schall, or Sherin
Mahdavian, of the Schall Law Firm, 1880
Century Park East, Suite 404, Los Angeles, CA 90067, at
424-303-1964, to discuss your rights free of charge. You can also
reach us through the firm's website at www.schallfirm.com, or
by email at brian@schallfirm.com.
The class in this case has not yet been certified, and until
certification occurs, you are not represented by an attorney. If
you choose to take no action, you can remain an absent class
member.
The Schall Law Firm represents investors around the world and
specializes in securities class action lawsuits and shareholder
rights litigation.
This press release may be considered Attorney Advertising in
some jurisdictions under the applicable law and rules of
ethics.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20180810005245/en/
The Schall Law FirmBrian Schall, Esq.Sherin Mahdavian,
Esq.310-301-3335info@schallfirm.comwww.schallfirm.com
Ampio Pharmaceuticals (AMEX:AMPE)
Historical Stock Chart
From Apr 2024 to May 2024
Ampio Pharmaceuticals (AMEX:AMPE)
Historical Stock Chart
From May 2023 to May 2024